Founders
Quin is an MD, with further degrees in genetics, mathematics, and computational biology, and a doctorate in systems genomics, from Oxford and Cambridge Universities. He founded his first liver drug genomics company 15 years ago, co-steered Oxford University’s single-cell genomics consortium, and most recently founded the Cellular and Systems Genomics department for the leading metabolic biopharma (focused on fatty liver target discovery).
Quin Wills
CSO, Co-Founder
Jack is a biomedical engineer by training, with a background in bringing new technologies to market. His career spans management consulting, company creation, health technology and biopharma market launches. He helped to see one of the first blockbuster gene therapies through FDA approval and onto commercial launch.